Glenn Walker

936 citations

12 papers · 659 indexed · h-index 8

Impact in

Cellular and Molecular Neuroscience top 5%
- Neuroscience and Neuropharmacology Research
- Neurotransmitter Receptor Influence on Behavior
- Neuropeptides and Animal Physiology
Pharmacology top 5%
- Cannabis and Cannabinoid Research

Papers in ⓘ

Toxicology 4
- Forensic Toxicology and Drug Analysis 3
Cellular and Molecular Neuroscience 8
- Neuroscience and Neuropharmacology Research 5
- Neurotransmitter Receptor Influence on Behavior 4

Co-authors: Phillip M. Cowley (4 shared papers)Richard Goodwin (3 shared papers)Roger G. Pertwee (1 shared paper)Gemma L. Baillie (1 shared paper)Arthur Christopoulos (1 shared paper)Lorraine McIntosh (1 shared paper)Gillian Goodwin (1 shared paper)Fiona Thomson (1 shared paper)
Journals: Bioorganic & Medicinal Chemistry Letters (7 papers)Molecular Pharmacology (1 paper)European Neuropsychopharmacology (1 paper)Neuroscience (1 paper)FEBS Letters (1 paper)
Partner nations: United Kingdom Australia India

In The Last Decade

Glenn Walker

12 papers receiving 636 citations

Peers

Countries citing papers authored by Glenn Walker

Since Specialization

Citations

This map shows the geographic impact of Glenn Walker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Glenn Walker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Glenn Walker more than expected).

Fields of papers citing papers by Glenn Walker

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Glenn Walker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Glenn Walker. The network helps show where Glenn Walker may publish in the future.

Co-authors

The 25 scholars most cited alongside Glenn Walker, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Glenn Walker Line = papers co-authored together Glenn Walker links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

#	Work
1	Allosteric Modulation of the Cannabinoid CB1 Receptor Molecular Pharmacology ·M. R. Price, Gemma L. Baillie, Adèle Thomas, Lesley Stevenson, Morag Easson, Richard Goodwin, Adèle McLean, Lorraine McIntosh, Gillian Goodwin, Glenn Walker, Paul Westwood, Julia Marrs, Fiona Thomson, Phillip M. Cowley, Arthur Christopoulos, Roger G. Pertwee, Ruth A. Ross	2005	348
2	The glycine neurotransmitter transporter GLYT1 is an organic osmolyte transporter regulating cell volume in cleavage-stage embryos Proceedings of the National Academy of Sciences ·Candace L. Steeves, Mary‐Anne Hammer, Glenn Walker, Duncan R. Rae, Nicolas A. Stewart, Jay M. Baltz	2003	85
3	Discovery and SAR of Org 24598—A Selective Glycine Uptake Inhibitor Bioorganic & Medicinal Chemistry Letters ·Angus R. Brown, Ian Carlyle, John R. Clark, William Hamilton, Samuel Gibson, George McGarry, Sandra McEachen, Duncan R. Rae, Simon N. Thorn, Glenn Walker	2001	75
4	Molecular cloning and functional expression of the human glycine transporter GlyT2 and chromosomal localisation of the gene in the human genome¹ FEBS Letters ·John A. Morrow, Iain T. Collie, Donald R. Dunbar, Glenn Walker, Mansoor Shahid, David R. Hill	1998	56
5	Positive N-methyl-d-aspartate receptor modulation by selective glycine transporter-1 inhibition in the rat dorsal spinal cord in vivo Neuroscience ·Kevin J. Whitehead, S. Pearce, Glenn Walker, Hardy Sundaram, David R. Hill, Norman G. Bowery	2004	34
6	Identification of potent, soluble, and orally active TRPV1 antagonists Bioorganic & Medicinal Chemistry Letters ·Paul Ratcliffe, John Maclean, Lynn Abernethy, Tom Clarkson, Maureen Dempster, Anna-Marie Easson, Darren Edwards, Katy L. Everett, Helen Feilden, Peter Littlewood, Duncan McArthur, Deborah McGregor, Hazel McLuskey, Olaf Nimz, Lesley-Anne Nisbet, Ronnie Palin, Heather Tracey, Glenn Walker	2011	19
7	Design, synthesis, and structure–activity relationship study of bicyclic piperazine analogs of indole-3-carboxamides as novel cannabinoid CB1 receptor agonists Bioorganic & Medicinal Chemistry Letters ·Elizabeth M. Moir, Kazuya Yoshiizumi, Jim Cairns, Phillip M. Cowley, Morag Ferguson, Fiona Jeremiah, Takao Kiyoi, Richard Morphy, Jason Tierney, Grant Wishart, Mark York, Joseph F. Baker, Jean E. Cottney, Andrea K. Houghton, Petula McPhail, Andrew Osprey, Glenn Walker, Julia M. Adam	2010	16
8	Design, synthesis, and structure–activity relationship study of conformationally constrained analogs of indole-3-carboxamides as novel CB1 cannabinoid receptor agonists Bioorganic & Medicinal Chemistry Letters ·Takao Kiyoi, Mark York, Stuart Francis, Darren Edwards, Glenn Walker, Andrea K. Houghton, Jean E. Cottney, James Α. Baker, Julia M. Adam	2010	11
9	The discovery of novel indole-2-carboxamides as cannabinoid CB1 receptor antagonists Bioorganic & Medicinal Chemistry Letters ·Phillip M. Cowley, James Α. Baker, David R. Barn, Kirsteen Buchanan, Ian Carlyle, John K. Clark, Thomas R. Clarkson, Maureen R. Deehan, Darren Edwards, Richard Goodwin, David Jaap, Yasuko Kiyoi, Chris Mort, Ronald Palin, Alan Prosser, Glenn Walker, Nick Ward, Grant Wishart, Trevor M. Young	2010	6
10	The identification, and optimisation of hERG selectivity, of a mixed NET/SERT re-uptake inhibitor for the treatment of pain Bioorganic & Medicinal Chemistry Letters ·Derek Angus, Matilda Bingham, Dawn Buchanan, Neil A. Dunbar, Linsday Gibson, Richard Goodwin, Anders Haunsø, Andrea K. Houghton, Margaret Huggett, Richard Morphy, Susan Napier, Olaf Nimz, Joanna Passmore, Glenn Walker	2010	3
11	Pharmacokinetic optimisation of novel indole-2-carboxamide cannabinoid CB1 antagonists Bioorganic & Medicinal Chemistry Letters ·Phillip M. Cowley, James Α. Baker, Kirsteen Buchanan, Ian Carlyle, John K. Clark, Thomas R. Clarkson, Maureen R. Deehan, Darren Edwards, Yasuko Kiyoi, Iain Martin, Dawn Osbourn, Glenn Walker, Nick Ward, Grant Wishart	2011	3
12	P.3.f.002 Effect of the selective glycine re-uptake (GlyT-1) inhibitor Org 25935 on glycine levels in CSF and dialysates European Neuropsychopharmacology ·Nancy C. Andrews, Jin Ge, Glenn Walker, J. Schipper, Hugh Marston	2007	3

About Glenn Walker

Glenn Walker is a scholar working on Toxicology, Cellular and Molecular Neuroscience, Pharmacology, Biochemistry and Sensory Systems, having authored 12 papers that have together received 659 indexed citations. Recurring topics across this work include Neuroscience and Neuropharmacology Research (5 papers), Cannabis and Cannabinoid Research (5 papers), Neurotransmitter Receptor Influence on Behavior (4 papers), Forensic Toxicology and Drug Analysis (3 papers), Ion channel regulation and function (2 papers), Amino Acid Enzymes and Metabolism (2 papers), Pharmacological Receptor Mechanisms and Effects (2 papers) and Metabolism and Genetic Disorders (1 paper). The work is most often cited by research in Cellular and Molecular Neuroscience (371 citations), Pharmacology (248 citations), Biochemistry (92 citations), Toxicology (29 citations) and Molecular Biology (361 citations). Glenn Walker has collaborated with scholars based in United Kingdom, Australia and India. Frequent co-authors include Phillip M. Cowley, Richard Goodwin, Roger G. Pertwee, Gemma L. Baillie, Arthur Christopoulos, Lorraine McIntosh, Gillian Goodwin, Fiona Thomson, Julia Marrs and Paul Westwood. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Molecular Pharmacology, European Neuropsychopharmacology, Neuroscience and FEBS Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact